BP
ADAP

Ballentine Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Ballentine Partners’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,758
Closed -$15.9K – 891
2024
Q3 		$15.9K Buy
+16,758
New +$15.9K ﹤0.01% 844
2024
Q2 		– Sell
-14,489
Closed -$22.9K – 754
2024
Q1 		$22.9K Buy
+14,489
New +$22.9K ﹤0.01% 733